Pharmacology and antifungal properties of anidulafungin, a new echinocandin. - Wikidata - wikimedia - TriplyDB

Pharmacology and antifungal properties of anidulafungin, a new echinocandin.

Pharmacology and antifungal properties of anidulafungin, a new echinocandin.

http://www.wikidata.org/entity/Q37359613

about

Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination.Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis: review of the literature Pharmacokinetics of antifungal agents in children.Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections.Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin and its impact on use and costs: review of the literature.Invasive fungal infections in infants-focus on anidulafungin.Echinocandins: The Expanding Antifungal Armamentarium.Systemic Antifungal Agents: Current Status and Projected Future Developments.Biofilms and beyond: expanding echinocandin utility.Flash pulmonary oedema during anidulafungin administration.

P2860

Q33490772-CC781176-5648-45A4-BF0C-86EEC10D1ED7 Q35959484-6A829D1B-8F4C-4EA9-9A36-2A5CFAAC4121 Q36163345-8C2BC033-0C67-47EB-B199-97F4FF30BC5D Q37785979-724BE95E-7CAC-4CD6-B1E9-63F982A7EEAF Q37864429-55AF0F89-7945-4D93-93B7-81056F058DD4 Q38103854-EF102269-AF9D-476D-B515-DD2EC642B7F1 Q38633102-1B7A941B-1CB7-4E56-9FF8-933C8D3A7DC0 Q38796140-B3BF25A9-BD5D-421A-901B-57D0C20E3A3E Q47205366-EDA57609-FE5F-46A7-801E-81508D6A79F8 Q48220477-38AFC97E-6778-4B36-BAFB-95FE197F1F5B

P2860

Pharmacology and antifungal properties of anidulafungin, a new echinocandin.

http://www.wikidata.org/entity/Q37359613

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pharmacology and antifungal properties of anidulafungin, a new echinocandin.

@en

Pharmacology and antifungal properties of anidulafungin, a new echinocandin.

@nl

type

label

Pharmacology and antifungal properties of anidulafungin, a new echinocandin.

@en

Pharmacology and antifungal properties of anidulafungin, a new echinocandin.

@nl

prefLabel

Pharmacology and antifungal properties of anidulafungin, a new echinocandin.

@en

Pharmacology and antifungal properties of anidulafungin, a new echinocandin.

@nl

P1433

Q37359613-7B2542C6-5EE2-4957-8C31-4C8D5B4C60F1

P1476

Q37359613-6A5368D6-A9EF-4627-BF64-8AD393CBF039

P2093

Q37359613-6E154435-4980-413C-B6F8-E8003D4D11D9

Q37359613-B645E0A6-C3AB-4CAB-B94F-8F70905107ED

Q37359613-DECC0E28-4241-41FD-A69B-0BE92ABA719B

Q37359613-E38A0C40-1C33-4656-8CA4-41951480D295

P2860

Q37359613-018A118E-1D3A-4C9B-8D00-8DFE2891AF4F

Q37359613-0FD020A0-F902-43D5-A3AA-DA2DAA30B521

Q37359613-1D1D7122-6208-4180-A9D6-A8C92BAF4F01

Q37359613-26F6DEA3-B408-4DA0-AD79-5CA70D19B7BB

Q37359613-2810728C-A8A1-4E1C-8102-A953E36B7CFD

Q37359613-3BFEE04F-490A-4C6A-8B01-8CBDCBB5D552

Q37359613-3C5F7D12-6181-47E9-A7EA-CCB6ADF6E8BD

Q37359613-475D4BB6-4064-4B7C-89AF-5A80AD574D3A

Q37359613-487FF0AE-89DC-4C5C-9FEA-F757E519A60A

Q37359613-4A8D167F-A8E9-48A9-BDFE-EABEE8169ED5

P304

Q37359613-5467DE28-6D1A-4287-A6B6-A1D0B26E6983

P31

Q37359613-7E4DE28A-3B59-419D-97C2-69F9327C6C28

P356

Q37359613-1026D05B-133B-4CEC-90D3-70C51FDDC8E8

P407

Q37359613-678CDB57-9CCB-46DF-A62C-309456A09EC2

P433

Q37359613-B12B0B9C-0D30-4537-9E50-52560CD70BDA

P478

Q37359613-D6091F72-0D13-4465-B912-8E6A0571028A

P577

Q37359613-784946EC-02B1-442B-A29B-0FB579D775C9

P698

Q37359613-658574AB-F62F-4355-AD89-F38B41642180

P921

Q37359613-51C29CAA-F6BB-44DD-8CDC-0F400BCB3E02

Q37359613-B02F03CD-0923-4CCE-B81E-E6D5698FFFEF

P356

P1433

Pharmacotherapy

P1476

Pharmacology and antifungal properties of anidulafungin, a new echinocandin.

@en

P2093

Karim Anton Calis

http://www.w3.org/2001/XMLSchema#string

Kristina E Estes

http://www.w3.org/2001/XMLSchema#string

Scott R Penzak

http://www.w3.org/2001/XMLSchema#string

Thomas J Walsh

http://www.w3.org/2001/XMLSchema#string

P2860

Phase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia

Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin

Efficacies of two new antifungal agents, the triazole ravuconazole and the echinocandin LY-303366, in an experimental model of invasive aspergillosis

Echinocandin antifungal drugs

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase.

Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates.

Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients.

Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.

Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling

P304

17-30

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1592/PHCO.29.1.17

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19113794

http://www.w3.org/2001/XMLSchema#string

P921